Metabolic Dysfunction After Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer. [PDF]
Shaver AL +5 more
europepmc +1 more source
SPEN Inactivation Drives Resistance to Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer. [PDF]
Blinka S +11 more
europepmc +1 more source
Immunohistochemical evaluation of androgen receptor expression in endometrial carcinoma and its clinicopathological significance. [PDF]
Mohamed ASAE +3 more
europepmc +1 more source
Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting. [PDF]
Alkan O +3 more
europepmc +1 more source
Amino-Acid-Derived Androgen Receptor Modulators. [PDF]
Semenya J, Picazo E.
europepmc +1 more source
Beyond pairwise comparisons of androgen receptor signaling inhibitors in nonmetastatic castration-resistant prostate cancer. [PDF]
Hara S.
europepmc +1 more source
Similar androgen receptor expression in male and female AML. [PDF]
Prabhu KS +4 more
europepmc +1 more source
Targeting the Fatty Acid Binding Protein 5-Specificity Protein 1 Axis Restores Enzalutamide Sensitivity by Suppressing Androgen Receptor/Androgen Receptor Splice Variant 7 Signaling: Implications for Prostate Cancer Therapy. [PDF]
Abdulsamad SA +11 more
europepmc +1 more source
Targeting the Androgen Receptor and Associated Cofactors in Prostate Cancer: Novel Approaches and Future Perspectives. [PDF]
Dziubańska-Kusibab PJ +2 more
europepmc +1 more source
Androgen receptor-regulated ZNF419 modulates ferroptosis sensitivity via the ZDHHC20-GPX4 pathway in prostate cancer. [PDF]
Hou Y +9 more
europepmc +1 more source

